Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for treatment of sickle cell disease
2006-005889-40Phase 2Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of acetylcysteine in sickle cell disease (SCD), sponsored by Amsterdam University Medical Center. Primary endpoint: Laboratory markers of red cell and vascular activation. Started Nov 2006; status: active.
02
Drugs
acetylcysteine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on 2006-005889-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005889-40.